Drug Type Antibody |
Synonyms NR-AR C010, NRARC010 |
Target |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS mutant Colorectal Cancer | Discovery | KR | 18 Oct 2023 | |
KRAS Mutant Pancreatic Cancer | Discovery | KR | 18 Oct 2023 |